Sulfamato Hydroxamic Acid Metalloprotease Inhibitor, its Use in Preparation of Pharmaceutical Composition for Treatment of Conditions Associated with Pathological Matrix Metalloprotease Activity

摘要

1. Technical Result Increase in efficiency of treatment of conditions associated with pathological matrix metalloprotease activity. 2. Essence A compounds of formula wherein R1, R2, R3a, R3b and R20 are as described in the specification; use of this compound and pharmaceutically acceptable salts thereof for treatment of conditions associated with pathological matrix metalloprotease activity (MMP). 3. Field of Application Medicine. Tables: 221